Skip to main content
Premium Trial:

Request an Annual Quote

Correction: Oct 14, 2004 (rev. 1)


In the Sept. 30 article entitled “Dusting Itself Off From Restructuring, Sequenom Hopes New Service Will Help Revenue Growth,” Pharmacogenomics Reporter quoted Sequenom’s Mike Terry as saying that Applied Biosystems has exited the validated assay market. In fact, ABI continues to offer a variety of validated assays. ABI’s custom SNP genotyping assays are not all pre-validated, but are validated upon ordering.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.